Seeing Is Believing
Healthcare - Sector
VNDA is currently covered by 4 analysts with an average price target of $13. This is a potential upside of $6.06 (141.64%) from yesterday's end of day stock price of $5.38.
Vanda Pharmaceuticals's activity chart (see below) currently has 30 price targets and 35 ratings on display. The stock rating distribution of VNDA is 90.91% BUY and 9.09% HOLD.
Analysts average stock forecasts to be materialized ratio is 55% with an average time for these price targets to be met of 266.17 days.
Highest price target for VNDA is $21, Lowest price target is $7.5, average price target is $13.
Most recent stock forecast was given by MADISON EL-SAADI from B. RILEY on 10-Aug-2026. First documented stock forecast 20-Jun-2013.
Currently out of the existing stock ratings of VNDA, 10 are a BUY (90.91%), 1 are a HOLD (9.09%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 31-Dec-2025
$12
$6.78 (129.89%)
$14
Buy Since 31-Oct-2024
$20
$14.78 (283.14%)
$21
Hold Since 26-Feb-2022
$7.5
$1.49 (24.79%)
Buy Since 12-May-2021
$11
$4.99 (83.03%)
$13
Buy Since 06-Feb-2019
$13
$6.99 (116.31%)
$13
What is VNDA (Vanda Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on VNDA (Vanda Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on VNDA (Vanda Pharmaceuticals)?
Which analyst is the currently most bullish on VNDA (Vanda Pharmaceuticals)?
Which analyst is the currently most reserved on VNDA (Vanda Pharmaceuticals)?